News

November 9, 2020
IGM Biosciences to Present at Three Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. , Nov. 09, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present at three upcoming investor
Additional Formats
September 2, 2020
IGM Biosciences to Present at Four Upcoming Investor Conferences
MOUNTAIN VIEW, Calif. , Sept. 02, 2020 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies, today announced that Fred Schwarzer , Chief Executive Officer, will present at four upcoming investor
Additional Formats
Displaying 1 - 10 of 20